NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Th
Go back to NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Th| (NASDAQ: ELAB) | Delayed: 5.01 -0.2 (3.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.21 | 52 Week High | $ | |||
| Open | $5.21 | 52 Week Low | $ | |||
| Day High | $5.35 | P/E | N/A | |||
| Day Low | $5.01 | EPS | $ | |||
| Volume | 18,570 | |||||
